Functional and Cutaneous Treatment Outcomes With Intravenous Immunoglobulin for Eosinophilic Fasciitis: A Retrospective Study

CONCLUSION: Adverse effects of IVIG included headaches in 1 patient (14.3%) and rash in 2 patients (28.6%). There were no reported veno-occlusive or thromboembolic events associated with IVIG.  J Drugs Dermatol. 2024;23(4):8017.    doi:10.36849/JDD.8017e.PMID:38564381 | DOI:10.36849/JDD.8017

Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Bianca Obiakor Winnie Fan Rebecca Jacobson Jocelyn Gandelman Anna Haemel Source Type: research